Vaishali Pharma Limited

NSE VAISHALI.NS

Vaishali Pharma Limited Market Capitalization on January 31, 2025: USD 26.93 M

Vaishali Pharma Limited Market Capitalization is USD 26.93 M on January 31, 2025, a 8.80% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Vaishali Pharma Limited 52-week high Market Capitalization is USD 38.63 M on October 15, 2024, which is 43.43% above the current Market Capitalization.
  • Vaishali Pharma Limited 52-week low Market Capitalization is USD 18.26 M on June 05, 2024, which is -32.19% below the current Market Capitalization.
  • Vaishali Pharma Limited average Market Capitalization for the last 52 weeks is USD 24.43 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
SV Wall Street
NSE: VAISHALI.NS

Vaishali Pharma Limited

CEO Mr. Hemanth Damodar Pathak
IPO Date Aug. 22, 2017
Location India
Headquarters 706 to 709, Aravalli Business Center
Employees 27
Sector Healthcare
Industries
Description

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Similar companies

KREBSBIO.NS

Krebs Biochemicals & Industries Limited

USD 1.15

4.92%

ZOTA.NS

Zota Health Care Limited

USD 10.92

-0.24%

ALBERTDAVD.NS

Albert David Limited

USD 13.52

1.95%

BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

USD 0.64

5.12%

StockViz Staff

February 2, 2025

Any question? Send us an email